Sanket Koul

Rising affluence, longer life expectancy and changing family structures are drawing mainstream developers to premium senior living projects in India's major urban markets

The Drugs Consultative Committee has sought a detailed proposal from Rajasthan amid concerns that machinery from closed pharma units could be used to make spurious drugs

The Drugs Consultative Committee has sought the DGHS opinion and data on Merbromin's manufacture and use before deciding on its continued inclusion under Schedule K

Funding will be part of a new track under the PRIP scheme exclusively for start-ups and MSMEs at the initial research stage, with assistance of up to ₹50 crore per project

IHH says India remains a key strategic market as it plans to deepen its Fortis investment, despite a Supreme Court-ordered forensic audit into past transactions

A Bench of Justices Vikram Nath and Sandeep Mehta asked the Centre why the maximum retail price (MRP) of essential medicines such as cancer drugs could not be capped at 16 per cent

Consultants attribute premium rentals in key micro-markets to limited quality Grade A space and sustained occupier demand, even as rents vary significantly across locations

Medtech manufacturers and private hospitals back trade margin rationalisation but seek a fact-based approach that accounts for category-specific costs and procurement structures

Trust becomes first Reit to access funding from a commercial bank after RBI allowed direct financing to Reits in June 2026

Primus Partners says integrating Ayush into public health systems, insurance and primary care could help expand India's market to $213 billion by 2030 from $43 billion now

The five-year deal at Pritech Park SEZ includes renewal of an earlier lease for 441,000 sq ft and an additional 126,000 sq ft of office space

Drug regulator asks healthcare professionals and pharmacists to discourage indiscriminate use of NSAIDs and antibiotics, citing risks of kidney damage and CKD

Developers are becoming more calibrated in their launch strategies, while homebuyers are showing greater scrutiny around prices, payment terms and product quality

The venture aims to raise Rs 10,000 crore to build a network of 15,000-20,000 beds across more than 50 cities over the next five to six years

The platform has secured land parcels in Ghaziabad and Lucknow to develop about 1.5 million sq ft of built-up area across two premium residential projects

DCGI Rajeev Raghuvanshi says the panel includes AI experts and will discuss how AI used in drug discovery should be evaluated, approved and regulated

Health Ministry says stem cell therapy for autism must remain restricted to approved clinical trials, while unauthorised use could invite regulatory and disciplinary action.

Draft rules require CCTV surveillance for prescription drug sales at licensed premises and mandate that recordings be preserved for a minimum period of three months

Anarock survey shows 3BHKs account for 48% of buyer preferences, while demand is increasingly shifting towards homes priced between Rs 90 lakh and Rs 1.5 crore

Industry bodies back greater scrutiny of medical device pricing but differ on how gaps between hospital procurement costs and prices charged to patients should be assessed